Inventor · disambiguated record
Alfred Zippelius
Also filed as: ZIPPELIUS ALFRED
4 granted patents·3 pending applications·7 citations·filing 1998–2020
65Inventor score
Top patents by PatentIndex Score
7 records- 0185US10781262B2Combination therapy of T cell activating bispecific antigen binding molecules and PD-1 axis binding antagonistsHOFFMANN LA ROCHE·Filed 2017·Granted Sep 22, 2020·4 cites·20 claims
- 0261US2020199215A1Combination therapy with an anti-ang2 antibody and a cd40 agonistHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 0361US2015232548A1Combination therapy with an anti-ANG2 antibody and a CD40 agonistHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 0460US11613587B2Combination therapy of T cell activating bispecific antigen binding molecules and PD-1 axis binding antagonistsHOFFMANN LA ROCHE·Filed 2020·Granted Mar 28, 2023·0 cites·29 claims
- 0556US8519106B2Monoclonal human tumor-specific antibodyESSLINGER CHRISTOPH·Filed 2008·Granted Aug 27, 2013·1 cites·14 claims
- 0656US2018134780A1Combination therapy with an anti-ang2 antibody and a cd40 agonistHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 0732US6475727B1Primers and methods for the detection of disseminated tumor cellsMICROMET AG·Filed 1998·Granted Nov 5, 2002·2 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Alfred Zippelius files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →